Wahed FTSE USA Shariah ETF vs Philip Morris International Inc. — how do they compare? Wahed FTSE USA Shariah ETF trades at $73.61, while Philip Morris International Inc. trades at $186.18 (market cap $290.24B). The key difference: Philip Morris International Inc. pays a 3.16% dividend while Wahed FTSE USA Shariah ETF pays none, and Wahed FTSE USA Shariah ETF is trading nearer its 52-week high, Philip Morris International Inc. nearer its low. Which is the better fit depends on your goals.
| HLAL | PM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $73.60 | $200.17 |
52-Week Low | $55.52 | $144.33 |
Market Cap | — | $290.24B |
Enterprise Value | — | $333.36B |
Dividend Yield | — | 3.16% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $186.00, down 1.88% on the day, with a neutral technical signal. The stock shows strong profitability with a 25.56% net income margin and has beaten earnings estimates in two of the last three quarters. Recent news highlights a $500 million impairment charge and a lowered profit forecast due to cost pressures, though the IQOS brand was recognized as a top global brand. Analyst consensus remains bullish with a $211.17 price target.
The outlook is mixed; strong cash flow and brand strength support long-term value, but near-term headwinds from cost inflation and illicit market growth pose risks. The current valuation at a P/E of 25.57 appears fair given earnings resilience, making PM a hold for investors tolerant of sector-specific volatility.
Trailing returns across standard periods
Latest headlines on both assets
HLAL is an ETF that invests in Shariah-compliant US companies. It follows a rigorous screening process to exclude businesses involved in non-compliant activities like interest-based finance, alcohol, and gambling.
Read more on HLAL →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →